Digital detection of cognitive decline and the case of screening
1st May 2022
The Penn Program on Precision Medicine for the Brain (P3MB) seeks to understand the inter-related clinical, ethical, and policy implications of applying precision medicine to the brain and to translate these discoveries into practice. The power of P3MB is its multidisciplinary collaborations. The work is made possible by grants from the Alzheimer’s Association, Centers for Disease Control and Prevention, National Institute on Aging, and generous philanthropic support. Richard was invited to talk at the P3MB Colloquium in May 2022 to talk about Digital detection of cognitive decline and the case of screening
Citation: